Work

Supplemental Figure 3b from Phase Ib Study of Tirabrutinib in Combination with Idelalisib or Entospletinib in Previously Treated Chronic Lymphocytic Leukemia

Year: 2023

Type: supplementary-materials

Abstract: Supplemental Figure 3. Mean (SD) TIRA plasma concentration. Cycle 1 Day 8 data are shown in patients receiving TIRA monotherapy with A) TIRA/IDELA, and B) TIRA/ENTO*

DOI: 10.1158/1078-0432.22476723.v1

Authors: Alexey V. Danilov, Charles Herbaux, Harriet S. Walter, Peter Hillmen, Simon A. Rule, Ebenezer A. Kio, Lionel Karlin, Martin J.S. Dyer, Siddhartha S. Mitra, Ping Cheng Yi, Rita Humeniuk, Xi Huang, Ziqian Zhou, Pankaj Bhargava, Juliane M. Jürgensmeier, Christopher D. Fegan

Language: English

Topic: Chronic Lymphocytic Leukemia Research

Subfield: Genetics

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: gold

OpenAlex ID: W4361815554

Cites:

Cited by:

Related to: 10